For the first quarter of fiscal year 2017, Medtronic’s revenue decreased 1 percent to $7.166 billion and its non-GAAP diluted earnings increased approximately 14 to 16 percent to $1.03 per share.

Medtronic completed its acquisition of HeartWare International on Aug. 22, a deal intended to expand the company’s heart failure business.

A federal appeals court ruled that Deborah Heart & Lung Center could not pursue antitrust claims against a group of doctors, the New Jersey Law Journal reports.

Valeant Pharmaceuticals appointed Paul S. Herendeen as CFO and executive vice president of finance on Aug. 22.

A judge in Florida denied Branch Banking and Trust Company’s motion to dismiss a cardiologist’s Chapter 7 bankruptcy case, Bloomberg BNA reports. A medical practice owned by Eze D. Uche, MD, had a mortgage with BB&T and defaulted on the loan before bringing the mortgage current.

Two New Jersey residents were sentenced on Aug. 16 to more than six years in prison apiece for forging physician signatures and writing and interpreting fraudulent reports for diagnostic testing that were never interpreted by a licensed physician.

Providing financial incentives to low-income smokers led to increased long-term rates of smoking cessation, according to a study in Switzerland.

A simulation model of U.S. adults found that proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors were not cost-effective in patients with heterozygous familial hypercholesterolemia (HeFH) or atherosclerotic cardiovascular disease (ASCVD).